FDA grants clearance to Sonic Incytes' VDFF for liver health assessment [Yahoo! Finance]
Madrigal Pharmaceuticals, Inc. (MDGL)
Last madrigal pharmaceuticals, inc. earnings: 2/26 06:50 am
Check Earnings Report
US:NASDAQ Investor Relations:
madrigalpharma.com
Company Research
Source: Yahoo! Finance
The VDFF combines quantitative measures of ultrasound attenuation and backscatter, boasting a strong correlation coefficient of 0.85 with MRI-PDFF, the hospital-based gold standard for liver fat measurement. With a 95% accuracy as a classifier of patients with more than 5% MRI-PDFF, VDFF is claimed to be a significant advancement in the diagnosis of hepatic steatosis. In the US, metabolic dysfunction-associated steatotic liver disease (MASLD) impacts nearly 100 million individuals, with approximately 20% progressing to metabolic dysfunction-associated steatohepatitis (MASH), a chronic disease that can lead to cancer and death. Existing non-invasive methods for diagnosing MASH and MASLD, particularly those available at the point of care, have limitations, making VDFF's arrival particularly timely following the FDA clearance of the first MASH therapeutic. Arizona Liver Health Steatotic Liver Program director, chief medical officer, and chief of transplant hepatology Dr Naim Alkho
Show less
Read more
Impact Snapshot
Event Time:
MDGL
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
MDGL alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
MDGL alerts
High impacting Madrigal Pharmaceuticals, Inc. news events
Weekly update
A roundup of the hottest topics
MDGL
News
- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- FDA Grants 510(k) Clearance to Sonic Incytes' Velacur® Determined Fat Fraction (VDFF), a breakthrough for patients with MASLD and MASH [Yahoo! Finance]Yahoo! Finance
- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) was upgraded by analysts at StockNews.com to a "sell" rating.MarketBeat
- Why Is Madrigal (MDGL) Up 1% Since Last Earnings Report? [Yahoo! Finance]Yahoo! Finance
- Madrigal Pharmaceuticals, Inc. to Participate in the Morgan Stanley 22nd Annual Global Healthcare ConferenceGlobeNewswire